HELP Therapeutics Announces Nature Medicine Has Published HiCM-188 Clinical Trial Data for Advanced Ischemic Heart Failure

NANJING, CHINA, August 20, 2026 - (ACN Newswire via SeaPRwire.com) - Aug 19, HELP Therapeutics today announced the Nature Medicine publication of 12-month results from the HEAL-CHF clinical trial evaluating HiCM-188, an investigational allogeneic human iPSC-derived cardiomyocyte (hiPSC-CM) therapy for the treatment of severe ischemic heart failure. The randomized controlled trial…

Addressing Cross-Border Transit Demand at the New Huanggang Port: Weixin Pay, Wonder and Koon Wing Motors Join Forces to Introduce ‘Wonder Transit X’ Smart Mobility Platform, Driving Digital Transformation of Green Minibuses and Fostering Public Transit Integration Between HK and the Chinese Mainland

HONG KONG, August 20, 2026 - (ACN Newswire via SeaPRwire.com) - With the imminent inauguration of the new Huanggang Port, cross-border transport demand between Shenzhen and Hong Kong is set to rise further. To drive the digital transformation of Hong Kong’s green minibuses and facilitate cross-border travel between Hong Kong and…

Hengrui Pharma Reports 2026 Interim Results as Innovation and Globalization Continue to Drive Business Momentum

HONG KONG, August 19, 2026 - (ACN Newswire via SeaPRwire.com) - Hengrui Pharma (“Hengrui” or “the Company”) today announced its financial results for the first half of 2026. During the reporting period, innovative drugs remained the Company’s key growth driver, while globalization initiatives continued to validate the global value of Hengrui’s…

Onchain Foundation Becomes Strategic Shareholder of Trust Square Ecosystem AG to Accelerate Global Innovation Platform

ZURICH, SWITZERLAND, Aug 19, 2026 - (ACN Newswire via SeaPRwire.com) - Trust Square Ecosystem AG today announced that the Onchain Foundation has become a strategic shareholder of the company through a strategic investment, marking a significant milestone in Trust Square's transformation into a global ecosystem platform for emerging technologies.The investment…

Champion REIT Announces 2026 Interim Results

- Resilient occupancy across property portfolio reflecting proactive leasing efforts- Three Garden Road recorded positive rental reversion in selective renewal cases- Proactive retail tenant mix refinement driving positive impact on tenants’ sales- Successfully secured credit facilities for refinancing all debt due in 2026HONG KONG, August 19, 2026 - (ACN Newswire…

Guoquan (2517.HK) 2026 Interim Results: Dual Growth in Scale and Efficiency, Powered by the Dual Drivers of Membership Stickiness and Product Matrix

HONG KONG, August 19, 2026 - (ACN Newswire via SeaPRwire.com) - Guoquan Food (Shanghai) Co., Ltd. ("Guoquan" or the "Company"; stock code: 2517.HK), a leading one-stop home meal products brand in China, announced its interim results for the six months ended 30 June 2026, which have been reviewed by the Audit…

Focus Graphite Chairman Converts Final C$835,000 Loan to Equity at a Premium to Market

C$0.50-per-share conversion completes longstanding Chairman loan as Focus strengthens its financial position amid growing government and industry supportOTTAWA, ON, Aug 18, 2026 - (ACN Newswire via SeaPRwire.com) - Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) ("Focus" or the "Company"), a Canadian developer of high-grade flake graphite deposits and advanced graphite…

Tokyo Lifestyle Receives Independent Research Coverage from Broad Investment Securities; Note Highlights Asset-Light Shift and Global Expansion

NEW YORK, Aug 18, 2026 - (ACN Newswire via SeaPRwire.com) - Broad Investment Securities LLC, a U.S. SEC-registered investment adviser, has issued an independent fundamental research report on Tokyo Lifestyle Co., Ltd. (Nasdaq: TKLF), examining the Japanese consumer-products distributor’s business model, financial trajectory, channel mix and international expansion.Tokyo Lifestyle, formerly Yoshitsu…

China Lilang Announces 2026 Interim Results

HONG KONG, August 17, 2026 - (ACN Newswire via SeaPRwire.com) - China Lilang Limited (“China Lilang” or the “Company”, together with its subsidiaries, the “Group”; stock code: 1234) today announced its interim results for the six months ended 30 June 2026.Mr. Wang Dong Xing, Chairman and Non-Executive Director of China Lilang,…